TMFUltraLong

Sean Williams

A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the healthcare sector and investment planning. You'll often find him writing about Obamacare, marijuana, drug and device development, Social Security, taxes, retirement issues and general macroeconomic topics of interest.

TMFUltraLong’s Activity

Tue Mar 7

NL

Article

TMFUltraLong published an article 12:00 AM

Valeant's Possible Debt Deal Shows Its Management Team Is Completely Missing the Point

Valeant is so focused on extending its debt maturities and lowering its debt levels that it's ignored its two biggest issues.

NL

Article

TMFUltraLong published an article 12:00 AM

23 Things You Need to Know About the Republican Obamacare Replacement Bill

The Affordable Care Act's replacement plan offers a number of surprises.

Mon Mar 6

NL

Article

TMFUltraLong published an article 12:12 PM

Inflation Is Back: Now Get Ready to Deal With the Consequences

Could stocks be headed for a major sell-off?

NL

Article

TMFUltraLong published an article 10:10 AM

10 Tax Breaks Every Parent Needs to Know

Raising a child is expensive, but it can also be rewarding come tax time.

NL

Article

TMFUltraLong published an article 12:00 AM

Here's Why MannKind Corporation Remained Stuck in Reverse and Lost 24% in February

MannKind's reverse stock split gave investors the blues.

NL

Article

TMFUltraLong published an article 12:00 AM

3 Factors That Drove Exelixis, Inc. Higher By 19% in February

A sizable earnings beat and a bounty of new pipeline developments have investors rightfully excited.

NL

Article

TMFUltraLong published an article 12:00 AM

The Big Reason Bristol-Myers Squibb Company Stock Exploded 15% Higher in February

Buyout rumors got investors excited.

Sat Mar 4

NL

Article

TMFUltraLong published an article 7:35 AM

The Massive Tax Refund Mistake Millions of Americans Are Making

Taxpayers have good intentions with their refunds, but are suffering from poor execution.

Thu Mar 2

NL

Article

TMFUltraLong published an article 12:00 AM

Here's Why Endeavour Silver Corp. Lost Its Luster and Fell 23%

Weak production results in the fourth quarter sent Endeavour's shares into a full meltdown.

NL

Article

TMFUltraLong published an article 12:00 AM

Here's What's Behind Nektar Therapeutics' 20% Move Higher

Nektar's pipeline is creating a buzz on Wall Street.

NL

Article

TMFUltraLong published an article 12:00 AM

2 Reasons Coeur Mining, Inc. Suffered a Meltdown and Lost 26% in February

Despite being tarnished, Coeur's shares appear attractively valued after an earnings miss.

NL

Article

TMFUltraLong published an article 12:00 AM

Hecla Mining Company's 13% Decline in February, Explained

Hecla falls short of Wall Street's fourth-quarter profit forecast and pays the price.

Wed Mar 1

NL

Article

TMFUltraLong published an article 12:00 AM

Here's Why Intra-Cellular Therapies Inc.'s Shares Had a Greater Than 30% Intraday Swing

From down 20% to up 13%, this pipeline update has investors on edge.

NL

Article

TMFUltraLong published an article 12:00 AM

4 Reasons Johnson & Johnson Surged 8% in February

It was business as usual for J&J last month.

NL

Article

TMFUltraLong published an article 12:00 AM

The 2 Likely Reasons Silver Wheaton Corp. Tumbled 12% in February

This mine shutdown probably has investors on edge, but it shouldn't.

NL

Article

TMFUltraLong published an article 12:00 AM

The Dow Just Hit 21,000, but Where's All the Hoopla?

It's time to ignore Wall Street's pedestaling of arbitrary milestones once and for all.

NL

Article

TMFUltraLong published an article 12:00 AM

Can You Guess the Average Credit Score of Homebuyers in America?

Hint: It's probably better than you think.

NL

Article

TMFUltraLong published an article 12:00 AM

This Monumental Mistake Has Cost Warren Buffett $12 Billion (and Counting)

File this one as a not-so-Minnie blunder!

Tue Feb 28

NL

Article

TMFUltraLong published an article 12:00 AM

The Duo of Reasons Behind Kite Pharma Inc.'s 26% Move Higher

Positive clinical data and a favorable earnings report have Kite flying high.

NL

Article

TMFUltraLong published an article 12:00 AM

Here's Why Novavax, Inc.'s Share Price Went Down the Drain

Does Novavax's lead vaccine candidate have a path forward?

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.82
Player Rank 139 out of 74620
Score 8291.00
Score Change Today -68.39
Accuracy 88.53%
Active Picks 97
Total Picks 506
Best Pick FAZ (+351.11)
Worst Pick PCYC.DL (-8878.78)
Average Score per Pick 16.52
Charms Earned 16
Highest Rated Favorite TMFBabo
Go to TMFUltraLong’s CAPS page

Boards Stats & Trivia

CAPS All Star
Board Posts 3
Recs Received 11
People who have rec'd these posts 11
Recs to Posts Ratio (last 30 days) N/A
Threads Started 2
Threads Started Percentage 66.67 %
Most Frequent Board CAPS Feedback
Very First Post Tickering....Just a heads up... (10/14/2010)
Percentage of Posts Rec'd 100.00 %
Show TMFUltraLong’s 10 Latest Posts